Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash - Nicholas A. Trum, BS; Jasmine Zain, MD; Chelsea Abad, NP; Steven T. Rosen, MD; Christiane Querfeld, MD, PhD (Elsevier, 2021)